Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
giovedì, ottobre 22
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
HCA Healthcare Inc
HCA
NYSE
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$459.40
-6.35
-1.36%
Ult. Agg.: Oct 21, 4:00 PM
$459.40
-6.35
-1.36%
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Dividendi
Confronta
Rapporto azionario
Privacy Manager
Utili:
I risultati di Q3 2026 tra 5 giorni da adesso in mar ott 27th, prima dell'apertura del mercato
Conference call:
Conference call programmata per tra 5 giorni alle 10:00 AM
Clicca per vedere il webcast
HCA Healthcare Financials
HCA Healthcare (HCA) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Behind HCA's Q2 Beat: One-Time Medicaid Boost and a Growing Insurance Headwind
HCA's Q2 results beat expectations. Company resets 2026 guidance on HIX headwinds and decline in surgeries.
Priya Nigam
HCA Healthcare Analysts Slash Their Forecasts After Q2 Results
HCA Healthcare's Q2 earnings beat expectations with $20.23B in revenue and adjusted earnings of $7.59 per share. Analysts lower price targets.
Avi Kapoor
HCA Healthcare Surpasses Q2 Estimates With Strong Admissions Growth
HCA Healthcare beat Q2 revenue and earnings estimates as admissions rose, while a payer mix shift and lower surgical volumes weighed on results.
Vandana Singh
PRO
HCA Healthcare Affirms FY2026 GAAP EPS Guidance of $28.70-$30.50 vs $29.70 Est; Affirms FY2026 Sales Guidance of $77.000B-$79.500B vs $78.457B Est
HCA Healthcare (NYSE:HCA) affirms FY2026 GAAP EPS guidance from $28.70-$30.50 to $28.70-$30.50 vs $29.70 analyst estimate. Affirms FY2026 sales outlook from $77.000 billion-$79.500 billion to $77.000 billion-$79.500
Benzinga Newsdesk
PRO
HCA Healthcare Q2 Adj. EPS $7.59 Beats $7.02 Estimate, Sales $20.230B Beat $19.400B Estimate
HCA Healthcare (NYSE:HCA) reported quarterly earnings of $7.59 per share which beat the analyst consensus estimate of $7.02 by 8.12 percent. This is a 10.96 percent increase over earnings of $6.84 per share from the
Benzinga Newsdesk
Earnings Scheduled For July 24, 2026
Companies Reporting Before The Bell • Charter Communications (NASDAQ:CHTR) is likely to report quarterly earnings at $10.19 per share on revenue of $13.53 billion. • American Express (NYSE:AXP) is expected to report
Benzinga Insights
